Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2019-11-26
2026-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technology-Supported Treatment of Sleep Apnea in Prediabetes
NCT04225507
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
NCT01156116
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
NCT01629862
L-carnitine for Reducing Cardio-metabolic Risk in Patients With Obstructive Sleep Apnea
NCT02645942
Alterations in Postprandial Glucose and Lipid Metabolism in Patients With Obstructive Sleep Apnea
NCT00942110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Untreated
Untreated condition (obstructive sleep apnea)
No interventions assigned to this group
Continuous positive airway pressure (CPAP) treatment
Continuous positive airway pressure (CPAP) treatment
Continuous positive airway pressure
Continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA)
Niacin
Untreated, pharmacological suppression of lipolysis by Niacin
Niacin
Suppression of lipolysis by niacin infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous positive airway pressure
Continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA)
Niacin
Suppression of lipolysis by niacin infusion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prediabetic
* Sleep apnea
Exclusion Criteria
* Severe hypertension
* Taking medications that can confound assessments
* Any history of known bleeding disorders
* Any underlying disease likely to limit life span or increase risk of intervention
* Currently pregnant, trying to get pregnant or nursing
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
AdventHealth
OTHER
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esra Tasali, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB19-0593
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.